Home » Topics » BioWorld Science

BioWorld Science
RSS

Daiichi Sankyo presents in vitro and in vivo data for DS-1039

Nov. 6, 2019

Regeneron provides updates on phase III development program of Libtayo in NSCLC

Nov. 6, 2019

Initiation of phase Ib study of mavorixafor in severe congenital neutropenia

Nov. 6, 2019

Further interim data presented from phase Ib study of EDP-1815 in patients with psoriasis

Nov. 6, 2019

eFFECTOR Therapeutics initiates early clinical study of zotatifin in advanced solid tumors

Nov. 6, 2019

Cartesian initiates phase I/II study of its lead CAR-T candidate, Descartes-08

Nov. 6, 2019

HLX-11 receives IND application acceptance notification from NMPA

Nov. 6, 2019

Tau spreads quickly but kills slowly

Nov. 6, 2019

PARP degradation joins trapping, inhibition

Nov. 6, 2019

FDA approves influenza vaccine Fluzone High-Dose Quadrivalent

Nov. 5, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...